drugset / Trial / NCT01801280
Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this pharmacokinetic study is to examine a possible drug-drug interaction of Pantoprazole on the bioavailability mycophenolic acid.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1000 mg | — |
| Subject | Mycophenolate Mofetil | Small molecule | 1500 mg | — |
| Subject | Mycophenolate Mofetil | Small molecule | 2000 mg | — |
| Subject | Mycophenolate Sodium | Unknown | 720 mg | — |
| Subject | Mycophenolate Sodium | Unknown | 1080 mg | — |
| Subject | Mycophenolate Sodium | Unknown | 1440 mg | — |
| Subject | Pantoprazole | Other / unclassified | 40 mg | — |